文献速递冠心病

症状性HIV感染者急性冠脉综合征后血运重建治疗更保守:五年全国性分析

Abstract 10613: Symptomatic Human Immunodeficiency Virus Infected Patients Receive Less Aggressive Revascularization Management After Acute Coronary Syndrome, a 5-year Nationwide Analysis.
PubMed 文献 · Circulation · 2019-10-21

该研究基于2013至2016年美国全国住院患者样本,比较对照组、无症状HIV组和症状性HIV组急性冠脉综合征(ACS)患者接受心导管、经皮冠状动脉介入(PCI)和冠状动脉旁路移植(CABG)的比例。多因素回归显示,症状性HIV组接受心导管、PCI和CABG的比值比均显著低于对照组,而无症状HIV组与对照组无显著差异,提示症状性HIV患者存在治疗差异。

要点

  • 症状性HIV合并ACS患者接受心导管、PCI和CABG的比例显著低于对照组。
  • 无症状HIV合并ACS患者上述操作比例与对照组无显著差异。
  • 临床需关注症状性HIV患者ACS后血运重建治疗不足的问题。

核心结论

  • 症状性HIV感染ACS患者接受心导管和血运重建治疗较对照组更不积极,而无症状HIV患者无此差异。

研究设计与样本

  • 回顾性分析2013至2016年全国住院患者样本(Nationwide Inpatient Sample),共识别515,016例主要诊断为ACS的患者,其中2,066例(0.40%)合并HIV诊断。
  • 按对照组、无症状HIV组和症状性HIV组比较心导管、PCI和CABG的操作率,采用多因素回归分析。

主要发现

  • 症状性HIV组与对照组相比,心导管操作率显著降低(OR 0.62,95%CI 0.52-0.73)。
  • 症状性HIV组与对照组相比,PCI率显著降低(OR 0.80,95%CI 0.67-0.96)。
  • 症状性HIV组与对照组相比,CABG率显著降低(OR 0.70,95%CI 0.52-0.93)。
  • 无症状HIV组与对照组相比,心导管(OR 0.90,95%CI 0.78-1.05)、PCI(OR 1.13,95%CI 1.00-1.26)和CABG(OR 0.87,95%CI 0.72-1.04)均无显著差异。

临床怎么用

  • 对症状性HIV合并ACS患者,应警惕血运重建治疗不足的风险,评估是否存在治疗差异。
  • 无症状HIV合并ACS患者的血运重建策略可参照一般ACS人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction: Cardiovascular disease is a leading cause of morbidity and mortality in human immunodeficiency virus (HIV) infected adults, and should be managed more aggressively.Prior studies highlighted treatment disparities for Acute Coronary Syndrome (ACS) among HIV patients. This study aims at examining these disparities with the latest large cohort data. Hypothesis: HIV patient with ACS are as likely to receive cardiac revascularization related procedures compared to control group. Methods: We reviewed the Nationwide Inpatient Sample from 2013 to 2016 to identify patients with diagnosis of ACS (ST-elevation and non ST-elevation myocardial infarction, and unstable angina) to compare rates of cardiac procedures (Catheterization, Percutaneous Coronary Intervention - PCI - and Coronary Artery Bypass Graft - CABG) among groups of population of interest (control, asymptomatic HIV, symptomatic HIV). Results: Overall, 515,016 patients with primary diagnosis of ACS where identified and among them 2066 (0.40%) of ACS patients had diagnosis of HIV (asymptomatic and symptomatic). Multivariate regression analysis showed statistically significant lower procedural rates for catheterization (OR: 0.62, 95% CI: [0.52, 0.73]), PCI (OR: 0.80, 95% CI: [0.67, 0.96]) and CABG (OR: 0.70, 95% CI: [0.52, 0.93]) in symptomatic HIV compared to control group. For asymptomatic HIV patient group, no significant change of procedural rates were found compared to control group for catheterization, PCI and CABG (respectively OR: 0.90, 95% CI: [0.78, 1.05], OR: 1.13, 95% CI: [1.00, 1.26] and OR: OR: 0.87, 95% CI: [0.72, 1.04]). Conclusions: Analysis shows a treatment disparity for ACS for symptomatic HIV patients only as symptomatic HIV affected patients received less aggressive catheterization and revascularization management after ACS, compared to control group. However, this effect was not present for the asymptomatic HIV patient group.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Huang Lucas C, Wu L, Yue B, et al. Abstract 10613: Symptomatic Human Immunodeficiency Virus Infected Patients Receive Less Aggressive Revascularization Management After Acute Coronary Syndrome, a 5-year Nationwide Analysis. Circulation. 2019. PMID: 31633997. doi:10.1161/circ.140.suppl_1.10613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。